Decrypting lysine deacetylase inhibitor action and protein modifications by dose-resolved proteomics

Yun-Chien Chang,Christian Gnann,Raphael R. Steimbach,Florian P. Bayer,Severin Lechner,Amirhossein Sakhteman,Miriam Abele,Jana Zecha,Jakob Trendel,Matthew The,Emma Lundberg,Aubry K. Miller,Bernhard Kuster
DOI: https://doi.org/10.1016/j.celrep.2024.114272
IF: 8.8
2024-05-26
Cell Reports
Abstract:Chang et al. systematically measured the dose-dependent response of cancer cells to 21 KDAC inhibitors at the proteome, acetylome, and phosphoproteome levels. The data can be explored in ProteomicsDB and reveal KDAC inhibitor specificity, hundreds of substrates beyond histones, and that drug-responsive acetylation sites mostly reside within intrinsically disordered regions.
cell biology
What problem does this paper attempt to address?